Market News

The Triumph of Journey Medical: DERM Stock Surpasses Expectations in Q4 2023

by Ron Finklestien

Updated On: March 21, 2024 10:08 pm

DERM stock - DERM Stock Earnings: Journey Medical Beats EPS, Beats Revenue for Q4 2023

Source: iQoncept / Shutterstock

Journey Medical (NASDAQ:DERM) disclosed its performance for the fourth quarter of 2023.

Earnings per share for Journey Medical tallied up to 3 cents, soaring past the analyst forecast of -8 cents.
The company raked in revenue amounting to $15.26 million, marking a 1.31% victory over the anticipated revenue of $15.06 million by analysts.

InvestorPlace Earnings has unveiled an innovative approach by harnessing data from TradeSmith to automate the coverage of quarterly earnings reports. It distills crucial insights involving earnings per share and revenue, shedding light on how a company compares to analyst predictions. These articles are disseminated swiftly without human intervention, ensuring our readers are promptly informed of the latest figures. For any concerns or discrepancies, do reach out to us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/derm-stock-earnings-journey-medical-for-q4-of-2023/.